The investigator is testing the addition of venetoclax to 5-azacitidine and vorinostat followed by standard chemotherapy to enhance treatment response in AML patients.
The investigator is testing the addition of venetoclax to 5-azacitidine and vorinostat followed by standard chemotherapy to enhance treatment response in AML patients.
Venetoclax to Augment Epigenetic Modification and Chemotherapy
-
Children's Wisconsin, Milwaukee, Wisconsin, United States, 53226
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
1 Year to 25 Years
ALL
No
Medical College of Wisconsin,
Michael Burke, MD, STUDY_CHAIR, Medical College of Wisconsin
2027-01